
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
Author(s) -
Earle Bain,
Laura Shafner,
David Walling,
Ahmed A. Othman,
Christy ChuangStein,
John W. Hinkle,
Adam Hanina
Publication year - 2017
Publication title -
jmir mhealth and uhealth
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.356
H-Index - 50
ISSN - 2291-5222
DOI - 10.2196/mhealth.7030
Subject(s) - medicine , clinical trial , ambulatory , dosing , physical therapy